Author Archives: jldixonblog

While the burden of the costs of diabetes care cannot be refuted, policy-makers do not agree upon the sources of potential funding and strategies to address the burden.  How much does diabetes cost us?  In 2017, the estimated cost of diagnosed diabetes care was about $327 billion for America (ADA, 2018).   About $237 billion ofContinue reading “Sustaining Innovation Related to Healthcare Financing”

For so long, healthcare providers have not had technological innovations, restricting access to patient information and the ability to monitor patients.  Patients also have increasing access to health information, specifically with the use of patient portals.  With advancing technological opportunities to improve and personalize healthcare, and more informed consumers due to the availability of information,Continue reading “Impacts of Technology on Data and Privacy”

With the use of technology growing rapidly, it is no surprise that innovative technological solutions for managing diabetes are rapidly emerging, as well.   Since individuals with diabetes must regularly monitor blood glucose levels, they are dependent on technology to do so.  Since the population with diabetes is growing, technology and pharmaceutical companies are dumping moneyContinue reading “Private Sector Innovation Advancements”

“Simply put, in the absence of a radical shift towards prevention and public health, we will not be successful in containing medical costs or improving the health of the American people.” -President Obama (Alper, 2014) Only 3% of national health expenditures are used for preventative services, even though health depends largely on behavioral and environmentalContinue reading “The Influence of Public Sector Policies”

Key governmental agencies in policies related to diabetes include (Patton, et al., 2015): Agency for Healthcare Research and Quality (AHRQ) Centers for Disease Control and Prevention (CDC) Centers for Medicare and Medicaid Services (CMS) Deparment of Health and Human Services (HHS) Department of Veterans Affairs (VA) Food and Drug Administration (FDA) Health Resources and ServicesContinue reading “Related Roles & Relevant Regulatory and Statutory Mechanisms”

When considering respect for autonomy in healthcare policy related to diabetes, the person with diabetes or pre-diabetes should have the ability to make his or her own decisions based on personal values and beliefs (Longest, 2010). Regardless of whether educational treatment options will reduce a person’s incidence of diabetes or reduce costs, respecting patients’ autonomyContinue reading “Ethical Impact & Considerations”